Diffusion Pharmaceuticals DFFN

$ 4.4 11.68%

Quarterly report 2024-Q3
added 11-12-2024

Diffusion Pharmaceuticals Balance Sheet 2011-2024 | DFFN

Annual Balance Sheet Diffusion Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-17.9 M	-13.9 M	-7.99 M	-8.35 M	877 K	-19.2 M	-21.9 M	1.61 M	3.69 M	590 K
Long Term Debt	-	-	-	35.7 K	-	-	-	550 K	-	-	-	-	-
Long Term Debt Current	-	-	-	113 K	111 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	480 K	2.25 M	1.79 M	2.23 M	3.86 M	-	2.27 M	3 M	-	-
Total Current Liabilities	-	-	-	2.44 M	1.72 M	804 K	2.69 M	4.44 M	1.2 M	2.34 M	8.88 M	20.9 M	3.79 M
Total Liabilities	2.6 M	13.2 M	2.93 M	2.92 M	3.98 M	2.59 M	4.92 M	8.3 M	4.37 M	4.61 M	11.9 M	20.9 M	3.79 M
Deferred Revenue	-	-	-	444 K	-	-	-	-	-	-	-	-	-
Retained Earnings	-54.4 M	-52.3 M	-130 M	-106 M	-91.7 M	-79.9 M	-61.6 M	-60.2 M	-78.8 M	-75.3 M	-60.9 M	-56.7 M	-42.1 M
Total Assets	9.97 M	4.16 M	37.8 M	27.7 M	24.1 M	18.2 M	26.1 M	17.5 M	39.6 M	42.8 M	18.3 M	2.45 M	3.67 M
Cash and Cash Equivalents	7.79 M	4.09 M	37.3 M	18.5 M	14.2 M	7.99 M	8.9 M	1.55 M	2 M	21.9 M	255 K	312 K	98.4 K
Book Value	7.38 M	-9 M	34.9 M	24.8 M	20.1 M	15.6 M	21.2 M	9.18 M	35.3 M	38.2 M	6.47 M	-18.4 M	-113 K
Total Shareholders Equity	7.38 M	-33.3 M	34.9 M	24.8 M	20.1 M	15.6 M	21.2 M	9.18 M	-41.6 K	38.2 M	6.46 M	-18.4 M	-16 M

All numbers in USD currency

Quarterly Balance Sheet Diffusion Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.82 K	35.7 K	35.7 K	35.7 K	35.7 K	136 K	136 K	136 K	136 K	-	-	-	-	-	-	-	550 K	550 K	550 K	550 K	550 K	819 K	819 K	819 K	819 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.25 M	3.21 M	2.66 M	2.6 M	2.46 M	14.2 M	2.13 M	13.2 M	-	-	-	2.93 M	2.75 M	2.54 M	2.57 M	2.92 M	2.92 M	2.92 M	2.92 M	3.98 M	3.98 M	3.98 M	3.98 M	2.59 M	2.59 M	2.59 M	2.59 M	4.92 M	4.92 M	4.92 M	4.92 M	8.3 M	8.3 M	8.3 M	8.3 M	2.32 M	2.32 M	2.32 M	2.32 M	4.61 M	4.61 M	4.61 M	4.61 M	11.9 M	11.9 M	11.9 M	-	-	-	-	-	3.79 M	3.96 M	3.81 M	-
Deferred Revenue	-	1.4 M	572 K	-	547 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-64 M	-59.3 M	-57 M	-54.4 M	-52.1 M	-54.2 M	-52.8 M	-52.3 M	-142 M	-139 M	-135 M	-130 M	-127 M	-114 M	-111 M	-106 M	-106 M	-106 M	-106 M	-91.7 M	-91.7 M	-91.7 M	-91.7 M	-79.9 M	-79.9 M	-79.9 M	-79.9 M	-61.6 M	-61.6 M	-61.6 M	-61.6 M	-60.2 M	-60.2 M	-60.2 M	-60.2 M	-42.2 M	-42.2 M	-42.2 M	-42.2 M	-75.3 M	-75.3 M	-75.3 M	-75.3 M	-60.9 M	-60.9 M	-60.9 M	-60.9 M	-56.7 M	-56.7 M	-56.7 M	-56.7 M	-49.4 M	-42.2 M	-42.2 M	-
Total Assets	48.9 M	53.2 M	8 M	9.97 M	12 M	3.36 M	3.94 M	4.16 M	26.3 M	29.2 M	33.6 M	37.8 M	40.9 M	52.7 M	56.2 M	27.7 M	27.7 M	27.7 M	27.7 M	24.1 M	24.1 M	24.1 M	24.1 M	18.2 M	18.2 M	18.2 M	18.2 M	26.1 M	26.1 M	26.1 M	26.1 M	17.5 M	17.5 M	17.5 M	17.5 M	2.28 M	2.28 M	2.28 M	2.28 M	42.8 M	42.8 M	42.8 M	42.8 M	18.3 M	18.3 M	18.3 M	18.3 M	2.45 M	2.45 M	2.45 M	2.45 M	3.67 M	3.67 M	3.67 M	-
Cash and Cash Equivalents	7.74 M	10 M	6.37 M	7.79 M	10.4 M	650 K	2.61 M	4.09 M	4.79 M	5.97 M	9.87 M	37.3 M	40.3 M	43.3 M	46.6 M	18.5 M	18.5 M	18.5 M	18.5 M	14.2 M	14.2 M	14.2 M	14.2 M	7.99 M	7.99 M	7.99 M	7.99 M	8.9 M	8.9 M	8.9 M	8.9 M	1.55 M	1.55 M	1.55 M	1.55 M	2 M	2 M	2 M	2 M	2.34 M	21.9 M	21.9 M	21.9 M	255 K	255 K	255 K	255 K	312 K	312 K	312 K	312 K	98.4 K	98.4 K	98.4 K	-
Book Value	45.6 M	50 M	5.34 M	7.38 M	9.57 M	-10.8 M	1.82 M	-9 M	26.3 M	29.2 M	33.6 M	34.9 M	38.1 M	50.2 M	53.6 M	24.8 M	24.8 M	24.8 M	24.8 M	20.1 M	20.1 M	20.1 M	20.1 M	15.6 M	15.6 M	15.6 M	15.6 M	21.2 M	21.2 M	21.2 M	21.2 M	9.18 M	9.18 M	9.18 M	9.18 M	-41.6 K	-41.6 K	-41.6 K	-41.6 K	38.2 M	38.2 M	38.2 M	38.2 M	6.47 M	6.47 M	6.47 M	18.3 M	2.45 M	2.45 M	2.45 M	2.45 M	-113 K	-289 K	-140 K	-
Total Shareholders Equity	45.6 M	50 M	5.34 M	7.38 M	9.57 M	-35.1 M	-33.7 M	-33.3 M	-31.8 M	26.7 M	30.6 M	34.9 M	38.1 M	50.2 M	53.6 M	24.8 M	24.8 M	24.8 M	24.8 M	20.1 M	20.1 M	20.1 M	20.1 M	15.6 M	15.6 M	15.6 M	15.6 M	21.2 M	21.2 M	21.2 M	21.2 M	9.18 M	9.18 M	9.18 M	9.18 M	-41.6 K	-41.6 K	-41.6 K	-41.6 K	38.2 M	42.8 M	45.3 M	12.2 M	6.46 M	6.46 M	6.46 M	6.46 M	-18.4 M	-18.4 M	-18.4 M	-18.4 M	-16.1 M	-143 K	-143 K	-

All numbers in USD currency